ELIZABETH HINES: Open Payments
NPI 1619967098 · BRAZIL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 24 payments from 15 companies in 2025. Trend: 2023 $468 · 2024 $603 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| ABBVIE INC. | 4 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Exact Sciences Corporation | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $31 |
| Amgen Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
Products named: VRAYLAR, Cologuard Collection Kit, VOQUEZNA, OTEZLA, MOUNJARO, Auvelity, LEQVIO, JARDIANCE.
Industry payments across IN — which companies pay providers there.
